Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphi Gm Coppens

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Bulletin of the World Health Organization|November 10, 2015
Access to hepatitis C medicinesDanny J Edwards, Delphi Gm Coppens, Tara L Prasad, et al.
Regenerative Medicine|November 5, 2020
Regulating advanced therapy medicinal products through the Hospital Exemption: an analysis of regulatory approaches in nine EU countriesDelphi Gm Coppens, Helga Gardarsdottir, Marie L De Bruin, et al.
Regenerative Medicine|February 28, 2020
Publication rates and reported results in a cohort of gene- and cell-based therapy trialsDelphi Gm Coppens, Helga Gardarsdottir, Cornelis A van den Bogert, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Bulletin of the World Health Organization|November 10, 2015
Access to hepatitis C medicinesDanny J Edwards, Delphi Gm Coppens, Tara L Prasad, et al.
Regenerative Medicine|November 5, 2020
Regulating advanced therapy medicinal products through the Hospital Exemption: an analysis of regulatory approaches in nine EU countriesDelphi Gm Coppens, Helga Gardarsdottir, Marie L De Bruin, et al.
Regenerative Medicine|February 28, 2020
Publication rates and reported results in a cohort of gene- and cell-based therapy trialsDelphi Gm Coppens, Helga Gardarsdottir, Cornelis A van den Bogert, et al.
Pageof 1